Table 1

Summary of the human MBD polypeptides

Accession No. a)

Name

Search method / databases b)

Domains c)

MBD position d)


P51608

MECP2

a, b, c, d, e, f, g, ac, bc, cc

96–149

Q9UIS9

MBD1

a, b, c, d, e, f, g, ac, bc, cc

zf-CXXC

7–59

Q9UBB5

MBD2

a, b, c, d, e, f, g, ac, bc, cc

151–204

O95983

MBD3

a, b, c, d, e, f, g, ac, bc, cc

8–60

Q9Z2D7

MBD4

a, b, c, d, e, f, g, ac, bc, cc

HhH-GPD

82–135

Q9UIF9

BAZ2A/TIP5

e, f, g

AT_hook, DDT, PHD, bromodomain

526–577

Q9UIF8

BAZ2B

e, f, g

DDT, PHD, bromodomain,

549–600

Q96T68

CLLD8

e, f, g

SET

162–216

Q15047

SETDB1

e, f, g

SET

597–653

Q9P267

KIAA1461

e, f

PWWP

21–79

Q96Q00

KIAA1887

e, f

304–456


a) Accession numbers according to the SwissProt database. b) a = BLASTP, b = TBLASTN, c = TBLASTX, d = PSI-BLAST, e = Pfam, f = Ncbi, g = SSDB, ac = BLASTP in Celera database, bc = TBLASTN in Celera database, cc = TBLASTX in Celera database. c) domain nomenclature according to the Pfam database, all sequences contain an MBD in addition. d) position in amino acid sequence

Roloff et al. BMC Genomics 2003 4:1   doi:10.1186/1471-2164-4-1

Open Data